Catalyst Event
Amgen Inc (AMGN) · Other
From KEDI Nvidia Fixed Tech100 Index (KNVDT100)
6/1/2026, 12:00:00 AM
The European Commission granted marketing authorization for IMDYLLTRA® (tarlatamab) on 2026-06-01 for the treatment of ES-SCLC; expected to have a medium market impact of approximately 5% due to expanded market access.
Korean Translation
2026년 6월 1일 유럽 집행위원회(EC)가 소세포폐암(ES-SCLC) 치료제 임딜트라®(타를라타맙)의 판매 허가를 승인함. 시장 확대에 따른 약 5% 수준의 주가 영향이 예상됨.
Related Recent Events
Microchip Technology Inc (MCHP) · Earnings Release
Next quarterly earnings for Q1 2027 are expected to be released around August 6, 2026, expected. Low impact is estimated as this is a routine scheduling announcement.
8/6/2026, 12:00:00 AM
AppLovin Corporation (APP) · Earnings Release
AppLovin's Q2 2026 earnings release is expected around August 5, 2026, based on past reporting schedules expected. Low impact estimated as the announcement of a date typically precedes the actual market-moving results.
8/5/2026, 12:00:00 AM
Advanced Micro Devices Inc (AMD) · Earnings Release
Q2 2026 earnings release and conference call scheduled.
8/4/2026, 12:00:00 AM
Super Micro Computer Inc (SMCI) · Earnings Release
The Q4 2026 earnings release is scheduled for August 4, 2026. Low importance is estimated as no market reaction has occurred yet for this future date, expected.
8/4/2026, 12:00:00 AM
Comcast Corp (CMCSA) · Earnings Release
Comcast's Q2 2026 earnings release on July 30, 2026 scheduled. Medium importance is estimated as earnings reports often impact stock prices.
7/30/2026, 12:00:00 AM
KLA Corp (KLAC) · Earnings Release
Fiscal Q4 2026 earnings release on July 30, 2026, is expected to have a medium importance impact on the stock price, scheduled.
7/30/2026, 12:00:00 AM